BioSpace News Archive

Drug Development

Orna Proves Concept in Preclinical Oncology and DMD Models

Orna announced first-ever data from its lead isCAR program that validates both the technology and its LNP delivery platform. BioSpace spoke with ORNA CEO Tom Barnes.

May 16, 2022
·
3 min read
·
Heather McKenzie
Business

Sofinnova Nets $1B+ from Apollo to Accelerate Biotech Growth

Sofinnova Partners announced on Monday that it entered into a long-term strategic and financial partnership with Apollo to expand its presence in the life sciences.

May 16, 2022
·
2 min read
·
Hayley Shasteen
Researchers Continue to Build Toolbox as May Recognizes ALS

In honor of ALS Awareness Month, BioSpace spoke with leading researchers like Dr. Matthew Harms of Columbia University and Drs. Howard Berman and Stanley Appel at Coya Therapeutics.

May 16, 2022
·
6 min read
·
Heather McKenzie
Business

AbbVie, AstraZeneca See Value in what Cugene, Proteros Have to Offer

Cugene and AbbVie came together on autoimmune diseases and cancer, while Proteros and AstraZeneca expanded their collaboration on epigenetic cancer drugs.

May 16, 2022
·
3 min read
·
Mark Terry
Drug Development

Angion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis

Angion Biomedica Corp. announced U.S. Food and Drug Administration’s acceptance of an Investigational New Drug application supporting the clinical development of ANG-3070 in idiopathic pulmonary fibrosis and clearance to begin a Phase 1b study of ANG-3070 in patients with IPF.

May 16, 2022
·
6 min read
Business

Axion BioSystems Welcomes Biotech Industry Leader Kevin Gould as New CEO

Axion BioSystems, a leading life science tools company focused on advanced live-cell assay platforms, announces that Kevin Gould has been appointed the company’s Chief Executive Officer, effective immediately.

May 16, 2022
·
3 min read
Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement

ValnevaSE announced that it has received a notice from the European Commission of intent to terminate the advance purchase agreement for Valneva’s inactivated whole-virus COVID-19 vaccine candidate VLA2001.

May 16, 2022
·
6 min read
Human Microbiome Market Growth Rate of 31.1 % over the Forecast years (2022-2029) – Global Industry Analysis

The corporate intelligence reports predict that the global human microbiome market will record an astounding compound annual growth rate of 31.1 % over the forecast years i.e. 2023 to 2029.

May 16, 2022
·
9 min read
Hospital Microbiology Testing Market: Increasing prevalence of various chronic diseases to drive the market

Albany NY, United States: The manufacturers and players working in the global hospital microbiology testing market offer various types of tests, including fungal, viral, and bacterial.

May 16, 2022
·
6 min read
Genetic Disease Diagnostic Market: Growing incidences of genetic disorders across the globe to drive the market

The genetic disease diagnostic market is anticipated to present substantial growth across the forecast period of 2021-2031 on the back of the rising prevalence of genetic diseases around the world.

May 16, 2022
·
6 min read